PONIX AWARDED $5 MILLION USDA GRANTTO BREAK “GROUND” ON CLIMATE-SMART AGRICULTURE IN GEORGIA

Through USDA’s Partnerships for Climate-Smart Commodities Program, the Initiative isRecruiting 24 Minority and Underserved Georgia Farmers to Adopt Hydroponic Farming ATLANTA (April 22, 2024) – The Coalition of Food Security (CFS), led byminority-owned AgTech start-up, Ponix, is implementing a $5 million United StatesDepartment of Agriculture (USDA) grant, as part of the Partnerships for Climate-SmartCommodities program,…

Read More

Annoviant™ Awarded $2.99 Million NIH Grant to Advance TxGuard™ Pulmonary-Valved Conduit for Pediatric Heart Disease

Funding represents a significant step forward in Annoviant’s mission to transform the landscape of pediatric cardiac care. Atlanta, April 16, 2024 – Annoviant™, Inc., a pioneering company with a breakthrough TxGuardTM technology platform for soft-tissue healing, currently focused on cardiovascular field, proudly announces receipt of a $2.99 million grant (SBIR Phase 2b) from the National Institutes of Health (NIH). This grant aims to propel the development and commercialization of its revolutionary TxGuard™…

Read More

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication

January 16, 2024 08:00 ET| Source: Aruna Bio BOSTON and ATHENS, Ga., Jan. 16, 2024 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a pioneer in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program,…

Read More

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023 November 16 2023, ATLANTA– Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced a $23.6 million grant from the Bill & Melinda Gates Foundation that will fund mass production of needle-free vaccines.  The manufacturing facility will…

Read More

Echoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast

In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…

Read More

Life Sciences Leaders, Advocates Launch New Partnership to Promote Benefits of Pro-Innovation Mergers & Acquisitions

Partnership for the U.S. Life Science Ecosystem to raise awareness on importance of mergers and acquisitions in advancing future cures and treatments WASHINGTON, D.C. – More than thirty leading organizations from across the life sciences today launched the Partnership for the U.S. Life Science Ecosystem (PULSE), a coalition to raise awareness of the fundamental role…

Read More